| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 132 |
| 1 | ETANERCEPT | 95 |
| 2 | EPINEPHRINE | 68 |
| 3 | INTERFERON BETA-1A | 46 |
| 4 | TIRZEPATIDE | 29 |
| 5 | METHOTREXATE | 28 |
| 6 | METHOTREXATE SODIUM | 28 |
| 7 | EVOLOCUMAB | 24 |
| 8 | INSULIN GLARGINE | 17 |
| 9 | OMEPRAZOLE MAGNESIUM | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOY ISOFLAVONES | 1 | 0.0128 |
| 1 | ADALIMUMAB-ADBM | 1 | 0.0037 |
| 2 | TESTOSTERONE ENANTHATE | 4 | 0.0024 |
| 3 | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM | 7 | 0.0013 |
| 4 | EPINEPHRINE | 68 | 0.0010 |
| 5 | PEPPERMINT OIL | 1 | 0.0009 |
| 6 | DISULFIRAM | 1 | 0.0009 |
| 7 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 1 | 0.0008 |
| 8 | ERGOCALCIFEROL | 14 | 0.0005 |
| 9 | LEBRIKIZUMAB-LBKZ | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 101 |
| 1 | Catecholamine [EPC] | 68 |
| 2 | alpha-Adrenergic Agonist [EPC] | 68 |
| 3 | beta-Adrenergic Agonist [EPC] | 68 |
| 4 | GLP-1 Receptor Agonist [EPC] | 66 |
| 5 | Interferon beta [EPC] | 47 |
| 6 | Insulin Analog [EPC] | 32 |
| 7 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 29 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 26 |
| 9 | PCSK9 Inhibitor [EPC] | 26 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | PCSK9 Inhibitor [EPC] | 26 | 0.0010 |
| 2 | Aldehyde Dehydrogenase Inhibitor [EPC] | 1 | 0.0009 |
| 3 | Catecholamine [EPC] | 68 | 0.0008 |
| 4 | Provitamin D2 Compound [EPC] | 14 | 0.0005 |
| 5 | Interleukin-17A Antagonist [EPC] | 17 | 0.0005 |
| 6 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Interferon beta [EPC] | 47 | 0.0002 |
| 8 | Phenylalanine Metabolizing Enzyme [EPC] | 2 | 0.0002 |
| 9 | Bismuth [EPC] | 1 | 0.0002 |